PHILADELPHIA — A new drug designed to ward off Alzheimer’s is being tested at more than 100 sites around the world, including the University of Pennsylvania. Called lecanemab, it consists of antibodies that bind to the abnormal proteins that accumulate in the brains of people with Alzheimer’s. Previous efforts to
PHILADELPHIA â A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania. Called lecanemab, it consists of antibodies that bind to the abnormal proteins that accumulate in the brains of people with Alzheimer's. Previous efforts to target these proteins have resulted in little to no improvement in patient .
/PRNewswire/ Quadriga Partners, LLC ("Quadriga"), an investment bank and transaction advisory group that works closely with companies in the healthcare.
Quadriga Partners advised Keystone Clinical Studies on its partnership with Flourish Research, a portfolio company of NMS Capital streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Quadriga Partners, LLC ("Quadriga"), an investment bank and transaction advisory group that works closely with companies in the healthcare.